Banner

News

Video

Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1

Fact checked by:

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

With growing popularity, GLP-1 RAs antidiabetes and antiobesity drugs have taken a place in contemporary medicine on par with HIV/AIDS drugs in the 1990s and birth control drugs in the 1950s and 1960s — and maybe surpassed those medicines that revolutionized health care. Alliance for Pharmacy Compounding CEO Scott Brunner, CAE, explains the context of physician prescription and patient demand in just the last two to three years.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Videos
AI on Trial: A conversation with Deepika Srivastava, chief operating officer at The Doctors Company
AI on Trial: The future of liability in an AI-driven health care system
© 2025 MJH Life Sciences

All rights reserved.